About Us

Your scientific partner for drug and in-vitro diagnostic development.

Pacific Biomarkers is a biomarker testing services provider, supporting pharmaceutical, biotech and in-vitro diagnostic (IVD) manufacturing companies through preclinical and Phase I-IV studies of drug and IVD development.

Pacific Biomarkers has an established reputation for expertise, flexibility, protocol consultation, and outstanding client services that has propelled the company to a prominent position in the rapidly growing pharmaceutical outsourcing industry. With over 300 fully CLIA validated assays and an extensive network of scientific, regulatory, and technology expertise, Pacific Biomarkers is the service provider of choice for many leading international drug manufacturers in the race to bring products to market as quickly and cost effectively as possible.

Pacific Biomarkers provides accurate, reliable analyses, and responsive service to sponsors and investigative sites. Pacific Biomarkers collaborates with sponsors to develop, validate, improve analytical methods, and provide technical consultation for protocol design. Our services are customized on a project specific basis which allows Pacific Biomarkers to be more flexible to meet the needs of our clients.

Pacific Biomarkers is a CAP accredited and CLIA certified laboratory. Pacific Biomarkers also provides GLP compliant biomarker laboratory services.

Company History

Originally named Pacific Biometrics, Inc., Pacific Biomarkers was founded in 1989 as a spin-off from the University of Washington Lipid Research Center, Dept. of Medicine. Founders Dr. Elizabeth Leary and Russ Warnick had a vision for global standardization of lipid testing. When the CDC initiated the Cholesterol Reference Method Laboratory Network (CRMLN), Pacific Biomarkers became a member of this network: three labs in the U.S. and 11 globally. For 20 years, Pacific Biomarkers provided lipid reference and standardization services for in-vitro diagnostic manufacturers and clinical laboratories.

During this time, Pacific Biomarkers began consulting with pharmaceutical companies to support drug development. This clinical trial support has now become a core business of the company. Traditionally, our therapeutic focus has been cardiovascular and musculoskeletal diseases, diabetes, obesity, metabolic syndrome, and inflammation. Today, we have evolved to meet the needs of our customers, providing biomarker support across a wide range of therapeutic areas.

In 2007, Pacific Biomarkers expanded its capabilities into immunogenicity testing, cell based assay services, and novel biomarker development. Shortly after in 2009, Pacific Biomarkers officially changed its name to Pacific Biomarkers to better reflect our business. In an effort to expand our clinical trial testing to Asia, Pacific Biomarkers partnered with Syngene International Ltd. and Wuxi AppTech in 2011 and 2014, respectively. Through these strategic collaborations, we can offer our 300+ CLIA validated biomarkers across diverse therapeutic areas in Asia with added capabilities within immunogenicity and cell based functional assays in a cost effective business model.

More recently in 2015, we introduced the Pacific Biomarkers Mobile App; an interactive platform that provides access to innovative tools such as the BIOMARKER NAVIGATOR and allows you to create biomarker information reports instantly from our broad biomarker testing menu.

Management Team

Benoit Bouche Ph.D. AMP

Chief Executive Officer

Benoit spent over 30 years growing healthcare businesses and solving fast growth-related issues as an entrepreneur, advisor or independent board member. He created and led an advisory firm, a central lab, and a clinical project monitoring unit, the three business units of what became the leading clinical stage CRO in Continental Europe in the late nineties. He sourced and led the execution of over 40 M&A transactions and financing rounds for biotechnology and medical device companies, or CROs. Benoit has a dual scientific (Pharm.D Pharmacy 1984; PhD Pharmaceutical Sciences/Biotechnology 1986) and business (Advanced Management Program Harvard Business School 2002) education.

+
-
maximize
minimize

Timothy J McGrath

Chief Operating Officer

With over 30 years of general management and global operations experience, Tim joined the merged Neomed Labs/Pacific Biomarkers in March 2019 with a focus on the integration of business operations to ensure efficiency and bring best market practices on board. Tim has worked extensively in laboratory and commercial settings, including Quintiles Transnational and Q2 Solutions, where he served as Global Head for Bioanalytical, Immunoassay, and Absorption, Distribution, Metabolism and Excretion (ADME) laboratories. He was responsible for multiple sites in the U.S. and Europe and was the Head of Central Labs in the Americas with sites in North and South America with over 500 employees. In the COO role, Tim has global responsibility for Laboratory Operations, Project Management, Data Management, Quality Assurance, and Information Technology. He graduated from the University of Massachusetts with a degree in Business Management

+
-
maximize
minimize

Abigail Brus

Site Head and Vice President of Project Management and Operations

Abigail Brus joined the Company in February of 2019 and serves as Site Head and Vice President of Project Management and Operations. In her current position, Ms. Brus manages all laboratory, project management and facilities operations at Pacific Biomarkers. Ms. Brus received a Bachelor of Science degree in Microbiology from the University of Kansas in Lawrence, Kansas. Additionally, she received her Cytotechnologist and Specialist in Laboratory Safety Certifications through the American Society for Clinical Pathology (ASCP). Ms. Brus brings over 20 years of Life Sciences experience to her role at Pacific Biomarkers. Abigail worked at Covance Central Laboratories, spending over 11 years in a variety of Project Management, Leadership and Operations roles, leading the launch of the Vaccines and Novel Immunotherapeutics department in 2015. In 2018, Ms. Brus joined Q2 Laboratory Solutions as Associate Clinical Operations Director, managing and enhancing strategic client relationships throughout the lifecycle of each project and portfolio.

+
-
maximize
minimize

Tim Hynes

Vice President of Business Development

P: 760-522-0042


Tim Hynes joined Pacific Biomarkers in 2016 and serves as Vice President of Business Development.  In this capacity he is responsible for managing all business development activities, oversees the business development executives as well as all marketing initiatives.  Mr. Hynes comes to Pacific Biomarkers with over 25 years in the industry having held positions with global CROs, Central Laboratories and Contract Manufacturing Organizations.  He most recently served with PPD Central Laboratories as a senior business development executive.  His comfort level extends from the global pharma and biotech client as well as the emerging players so prevalent throughout the industry. He is well published and earned his BS degree from Southampton College, part of Long Island University, in Marine Science.

+
-
maximize
minimize

Tonya K. Aggoune

Vice President of Information Technology and Data Services

P: 206-816-1729


Tonya Aggoune is Vice President of Information Technology and Data Services which includes responsibility for Data Management and Information Technology Departments of Pacific Biomarkers. Tonya is also the Data Protection Officer (DPO) for Pacific Biomarkers. She joined the company in 1997 as the Manager of Information Systems, which included the data management and information technology functions.

Since joining Pacific Biomarkers as the head of Information Systems, Ms. Aggoune has been responsible for information technology (IT), computer operations, and the Laboratory Information Systems database. She is also the principle liaison between Pacific Biomarkers and client Data Management personnel to develop requirements for reporting, data transfer, and other custom database applications for pharmaceutical and diagnostic studies.

Ms. Aggoune has a BA in Biological Sciences and BS in Electrical Engineering. Her background includes extensive experience as a systems engineer in aerospace research and laboratory information systems in the Health Care industry. As an engineer at Boeing Aerospace, she designed and developed prototypes for computer based training systems, paper-less maintenance systems, and command/control/communication systems. She later joined National Health Laboratories (later became LabCorp) as Assistant Manager of Information Systems where she was able to bring together her experience with computer systems/software and her background in biological sciences.

+
-
maximize
minimize

Crystal Sung, Ph.D.

Director of Biomarker Sciences

Crystal Sung is Director of Biomarker Sciences at Pacific Biomarkers. She has over 15 years of pharma/biotech experience in Biologics Development with scientific expertise in different therapeutic modalities. Crystal is specialized in Diagnostics/Clinical Immunology and Biomarkers with extensive knowledge in assay development, validation and companion diagnostic development.

Crystal holds a Ph.D. degree in Pathology from The Ohio State University, College of Medicine with post-doctoral research trainings at Northwestern University Medical School followed by accredited Clinical Immunology Fellowship trainings at 3 different institutes in Chicago. Crystal is a member of AAPS, AMLI and AACC. Crystal Sung is a Diplomate of American Board of Medical Laboratory Immunology (ABMLI). She has over 10 years of experience in directing high complexity CLIA labs and currently holds New York State Certificate of Laboratory Director Qualification (CoQ).

+
-
maximize
minimize

Cheikh Kane, Ph.D.

Global Director of Bioanalytical Services

P: 206-816-1767


Dr. Cheikh Kane joined the Company in 2018 and serves as its Director of Bioanalytical Services, bringing with him 15 years of Immunoassay experience for large molecules. Dr. Kane brings scientific depth, regulatory knowledge, and extensive problem solving skills in the immunogenicity assay development area. He has served several critical positions within the industry spanning CROs, Biotech and Pharma organizations bringing a unique perspective to the Company’s Business Development and Scientific efforts. In his role as Director of Bioanalytical Services, Dr. Kane manages the bioanalytical laboratory and provides scientific leadership and technical support to the Company’s testing services. Prior to joining Pacific Biomarkers, Dr. Kane served as Principal Scientist and Group leader at Boehringer Ingelheim-US. Prior to that position, he was a Senior Research Scientist in the Immunogenicity group at Charles River Laboratories in Canada. Dr. Kane earned a PhD in Virology (Microbiology)-Immunology from National Institute of Scientific Research (INRS), Canada.

+
-
maximize
minimize

Our Facility

Built in 2012 from a cold shell, we have completely customized over 21,000 sq. ft. of expandable space including a CAP/CLIA certified laboratory.

Pacific Biomarkers:
The Value of Expertise

Download PDF

Pacific Biomarkers:
The Value of Science

Download PDF

Pacific Biomarkers:
The Value of Client Team

Download PDF

Strategic Alliances

Download PDF